{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:49:29Z","timestamp":1649162969535},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.endonu.2010.10.013","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:57:22Z","timestamp":1298109442000},"page":"199-201","source":"Crossref","is-referenced-by-count":1,"title":["Glucagonoma maligno como causa infrecuente de diabetes de inicio"],"prefix":"10.1016","volume":"58","author":[{"given":"Raquel","family":"Guerrero V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Oliva Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Ignacio","family":"Cuenca Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"S\u00e1nchez Alberdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Navarro Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2010.10.013_bib0005","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12032-007-0011-2","article-title":"Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years","volume":"24","author":"Kindmark","year":"2007","journal-title":"Med Oncol."},{"key":"10.1016\/j.endonu.2010.10.013_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1510531","article-title":"The glucogonoma syndrome and necrolytic migratory erythema: a clinical review","volume":"151","author":"Van Beek","year":"2004","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endonu.2010.10.013_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199603000-00002","article-title":"The glucagonoma syndrome: clinical and pathology features in 21 patients","volume":"75","author":"Wermers","year":"1996","journal-title":"Medicine."},{"key":"10.1016\/j.endonu.2010.10.013_bib0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0009-739X(04)72384-2","article-title":"S\u00edndrome del glucagonoma y seudoglucagonoma","volume":"76","author":"Echenique-Elizondo","year":"2004","journal-title":"Cir Esp."},{"key":"10.1016\/j.endonu.2010.10.013_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-4632.2004.01844.x","article-title":"Necrolytic migratory erythema: clinicopathologic study of 13 cases","volume":"43","author":"Pujol","year":"2004","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.endonu.2010.10.013_bib0030","first-page":"637","article-title":"Glucagonoma: a recent series of 7 cases","volume":"91","author":"Vauleon","year":"2004","journal-title":"Bull Cancer."},{"key":"10.1016\/j.endonu.2010.10.013_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MPA.0b013e3181ebaffd","article-title":"NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor","volume":"39","author":"Vinik","year":"2010","journal-title":"Pancreas."},{"key":"10.1016\/j.endonu.2010.10.013_bib0040","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2010.10.013_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","article-title":"Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial","volume":"28","author":"Yao","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2010.10.013_bib0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/SLA.0b013e31815b9cae","article-title":"Pronostic score predicting suvival after resection of pancreatic neuroendocrine tumors","volume":"247","author":"Bilimoria","year":"2008","journal-title":"Ann Surg."}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092210003098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092210003098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T18:20:41Z","timestamp":1543947641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092210003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1575092210003098"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2010.10.013","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}